McKinsey analysis saw an increasing number of biotechs across platform areas integrating machine learning into their R&D processes.8For more on the potential impact of machine learning and AI in life sciences, see “;) The future of biotech: AI-driven drug discovery,” McKinsey, accessed November 10, 2023.
Applications of ML are not limited by modality, and as the technology matures, it may become an integral part of all biopharmaceutical research rather than a distinct category of biotechs. McKinsey analysis saw an increasing number of biotechs across platform areas integrating machine learning into their R&D processes.8For more on the potential impact of machine learning and AI in life sciences, see “;) The future of biotech: AI-driven drug discovery,” McKinsey, accessed November 10, 2023. Early-stage AI biotech start-ups funded in 2022 have focused on areas including the following: